Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease (Q83821644)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

chronic renal insufficiency

28 January 2020

main subject

1 reference

Constantinos J Stefanidis

inferred from title

author

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Ekaterini Siomou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Anna Challa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nikoleta Printza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Vasileios Giapros

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Fotini Petropoulou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Andromachi Mitsioni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Fotios Papachristou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

9 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1105-1114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21479768%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-011-1870-5

28 January 2020

exact match

0 references

cites work

Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism

1 reference

12 December 2020

OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis

1 reference

12 December 2020

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

1 reference

12 December 2020

FGF-23 in bone biology

1 reference

12 December 2020

Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis

1 reference

12 December 2020

Overview of the FGF23-Klotho axis

1 reference

12 December 2020

Bone mass, biochemical markers and growth in children with chronic kidney disease: a 1-year prospective study

1 reference

12 December 2020

Bone biopsy results and serum bone turnover parameters in uremic children

1 reference

12 December 2020

PTH differentially regulates expression of RANKL and OPG.

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.

1 reference

12 December 2020

Chronic kidney disease mineral and bone disorder in children

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

A prospective study of fibroblast growth factor-23 in children with chronic kidney disease

1 reference

12 December 2020

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

1 reference

12 December 2020

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

12 December 2020

Clinical relevance of FGF-23 in chronic kidney disease

1 reference

12 December 2020

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

12 December 2020

[Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure]

1 reference

12 December 2020

Children with chronic kidney disease: a 3-year prospective study of growth, bone mass and bone turnover

1 reference

12 December 2020

Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.

1 reference

12 December 2020

Circulating osteoprotegerin is not removed through haemodialysis membrane

1 reference

12 December 2020

Circulating biochemical markers of bone remodeling in uremic patients

1 reference

12 December 2020

Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure.

1 reference

12 December 2020

Serum osteoprotegerin and renal osteodystrophy

1 reference

12 December 2020

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

12 December 2020

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

12 December 2020

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

1 reference

12 December 2020

The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis

1 reference

12 December 2020

New equations to estimate GFR in children with CKD

1 reference

12 December 2020

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

1 reference

12 December 2020

The novel bone alkaline phosphatase B1x isoform in children with kidney disease

1 reference

12 December 2020

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment

1 reference

12 December 2020

Osteoprotegerin affects the responsiveness of fibroblast growth factor-23 to high oral phosphate intake

1 reference

12 December 2020